Home Search
cannabis - search results
If you're not happy with the results, please do another search
Strong association between vaping and binge drinking
A recent study involving over 50,000 US adolescents has revealed a strong association between vaping and binge drinking, and cannabis use.
Exploring preventive interventions for youth mental health issues
Mary Cannon has an international reputation in the field of psychiatry, particularly developmental psychiatric epidemiology and youth mental health.
The Psychedelic Renaissance: Exploring shifting attitudes towards psychedelic therapy
In a surprising turn of events, Prince Harry's public endorsement of the transformative power of psychedelic therapy has triggered a psychedelic resurgence in the UK.
Targeting the Cannabinoid Type-2 Receptor for Novel Anto-inflammatory Therapeutics
Type-2 cannabinoid receptor (CB2R) is a G-protein-coupled receptor (GPCR) and an essential element of the endocannabinoid system (ECS) [1].
Met Police misconduct: 1000 sexual allegations to be investigated against officers
800 Met Police officers are being investigated, facing sexual and domestic abuse claims and other accusations of potential Met Police misconduct.
An in-depth look at opioid dependence
Dr Gerard Sinovich, Lead Pain Specialist, provides an in-depth commentary on behalf of Cantourage Clinic concerning what we need to know about opioids and opioid dependence.
Michael Sassano – SOMAÍ Pharmaceuticals
Michael Sassano, CEO of SOMAÍ Pharmaceuticals
Michael Sassano was an early investor in the United States cannabis industry and now heads SOMAÍ Pharmaceuticals, a next-generation biotech company centred on the cultivation, manufacturing, and distribution of GMP-certified cannabinoid-containing pharmaceutical products throughout the European Union. SOMAÍ opened Europe’s largest cannabis manufacturing facility...
How clarity and standards can help the CBD Industry to thrive
Michael Sassano, CEO at SOMAÍ Pharmaceuticals, walks us through how clarity and standards can help the CBD Industry to thrive.
Day Tripper: is LSD and magic mushroom microdosing the future?
Kath Temple, Psychologist, discusses the history, politics and science behind LSD and magic mushroom microdosing.
The UK CBD Market: Cannabinoids, Consumers and Confusion
Savage Cabbage Ltd give insight into the UK CBD market, defining the differences in cannabinoid products and their roles in the industry.
Is CB₂R a hidden treasure trove for treating inflammatory diseases?
Expert scientists working on endocannabinoid system (ECS) trials explain how CB₂R can be used to treat inflammatory diseases.
Will CBD replace opioids?
America is gripped by opioid addiction and a dangerous opioid epidemic - could CBD be a viable replacement?
School children favour vaping over smoking or taking drugs
Fewer school children are smoking or doing drugs, but vaping use among 11 to 15-year-olds is increasing, a study from NHS Digital finds.
Sexual minorities more likely to have risky coping mechanisms
Sexual minorities are more likely to engage in risky coping mechanisms such as having unprotected sex, drinking and smoking.
Cannabinoids as an alternative to opioids for chronic pain
Cannabinoids with high THC-to-CBD ratios can help to improve moderate, short-term chronic pain band may be an alternative to opioids.
Mental health and perinatal depression in the US
The National Institute of Mental Health (NIMH) is the lead U.S. federal agency for research on mental illnesses.
Full spectrum CBD: What Sets Charlotte’s Web Apart
Here, Savage Cabbage explain why their full-spectrum Cannabidiol (CBD) products are different to others on the market.
Do labels efficiently tell you what’s in your weed strain?
Research finds that labels on weed often fail to adequately reflect products' chemical make-up and components of the weed strain.
Shifting sands in the UK CBD industry
Senior Associate David Hardstaff and Partner John Binns of BCL Solicitors explore shifting sands in the UK CBD industry.
Can predictive genomics make our healthcare systems more sustainable?
Dr Zisis Kozlakidis with Francesco Florindi, discuss predictive genomics and ask if it can help make our healthcare systems more sustainable.